{"text": ["AbbVie", "Sells", "$30", "Billion", "of", "Bonds", "to", "Fund", "Allergan", "Acquisition"], "created_at": "2019-11-12 22:12:59"}
{"text": ["US", "Indexes", "End", "the", "Day", "Higher", "Tuesday"], "created_at": "2019-11-12 21:40:35"}
{"text": ["Corporations", "Pile", "Into", "Bond", "Market", "as", "Borrowing", "Costs", "Drop"], "created_at": "2019-11-12 19:11:30"}
{"text": ["New", "Positive", "Data", "for", "RINVOQ\u2122", "(upadacitinib)", "on", "Signs", "and", "Symptoms", "in", "Patients", "with", "Ankylosing", "Spondylitis", "Presented", "at", "2019", "ACR/ARP", "Annual", "Meeting"], "created_at": "2019-11-12 16:15:00"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "Toyota,", "Netflix,", "AbbVie,", "Gilead", "and", "Fiserv"], "created_at": "2019-11-12 13:31:01"}
{"text": ["AbbVie", "Rises", "3%"], "created_at": "2019-11-12 11:56:00"}
{"text": ["AbbVie", "sells", "$30bn", "of", "bonds", "to", "finance", "Allergan", "takeover"], "created_at": "2019-11-12 11:46:13"}
{"text": ["AbbVie", "readies", "$30bn", "bond", "sale", "to", "finance", "Allergan", "takeover"], "created_at": "2019-11-12 10:14:36"}
{"text": ["AbbVie", "Eyes", "Up", "to", "$28", "Billion", "Bond", "Sale", "to", "Finance", "Allergan", "Deal:", "Report"], "created_at": "2019-11-12 10:00:00"}
{"text": ["AbbVie", "readies", "$27bn", "bond", "sale", "to", "finance", "Allergan", "takeover"], "created_at": "2019-11-12 03:47:49"}
